Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 5 (2008), Issue 12 (December)

1. Lack of observed association between high plasma osteoprotegerin concentrations and ischemic stroke risk in a healthy population.
   Clin Chem, 54(12): 1969-74. [Abstract] [Full-text]
2. Traumatic vertebral artery dissection and Wallenberg syndrome after a motorcycle collision.
   Am J Emerg Med, 27(1): 131.e1-3. [Abstract] [Full-text]
3. Hierarchical properties of the motor function sections of the Fugl-Meyer assessment scale for people after stroke: a retrospective study.
   Phys Ther, 88(12): 1554-67. [Abstract] [Full-text]
4. Transcranial magnetic stimulation study of expiratory muscle weakness in acute ischemic stroke.
   Neurology, 71(24): 2000-7. [Abstract] [Full-text]
5. Changes in NAA and lactate following ischemic stroke: a serial MR spectroscopic imaging study.
   Neurology, 71(24): 1993-9. [Abstract] [Full-text]
6. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.
   Circulation, 118(24): 2555-62. [Abstract] [Full-text]
7. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.
   Ann N Y Acad Sci, 1147: 383-94. [Abstract] [Full-text]
8. Susceptibility weighted imaging: a new tool in magnetic resonance imaging of stroke.
   Clin Radiol, 64(1): 74-83. [Abstract] [Full-text]
9. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.
   Lancet Neurol, 8(1): 48-56. [Abstract] [Full-text]
10. A modified suture technique produces consistent cerebral infarction in rats.
    Brain Res, 1246: 158-66. [Abstract] [Full-text]
11. Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy.
    FEBS J, 276(1): 46-57. [Abstract] [Full-text]
12. Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment.
    FEBS J, 276(1): 36-45. [Abstract] [Full-text]
13. Prediction of infarct growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast material.
    Radiology, 250(1): 184-92. [Abstract] [Full-text]
14. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population.
    Hypertension, 53(1): 28-34. [Abstract] [Full-text]
15. Location of single subcortical infarction due to middle cerebral artery atherosclerosis: proximal versus distal arterial stenosis.
    J Neurol Neurosurg Psychiatry, 80(1): 48-52. [Abstract] [Full-text]
16. Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy.
    J Neurol Neurosurg Psychiatry, 80(1): 41-7. [Abstract] [Full-text]
17. Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke model.
    Pharmacology, 83(1): 38-44. [Abstract] [Full-text]
18. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization.
    Arterioscler Thromb Vasc Biol, 29(1): 128-33. [Abstract] [Full-text]
19. Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.
    Am J Phys Med Rehabil, 88(1): 30-8. [Abstract] [Full-text]
20. Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor.
    Anesth Analg, 108(1): 280-7. [Abstract] [Full-text]
21. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
    J Am Coll Cardiol, 52(25): 2148-55. [Abstract] [Full-text]
22. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial.
    Lancet, 372(9656): 2132-42. [Abstract] [Full-text]
23. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients.
    Am J Cardiol, 103(1): 124-9. [Abstract] [Full-text]
24. Effect of electroacupuncture on motor recovery in a rat stroke model during the early recovery stage.
    Brain Res, 1248: 176-83. [Abstract] [Full-text]
25. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct.
    Brain Res, 1248: 22-30. [Abstract] [Full-text]
26. Landmark-referenced voxel-based analysis of diffusion tensor images of the brainstem white matter tracts: application in patients with middle cerebral artery stroke.
    Neuroimage, 44(3): 906-13. [Abstract] [Full-text]
27. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population.
    Circulation, 118(25): 2672-8. [Abstract] [Full-text]
28. Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department.
    Clin Chem, 55(1): 175-8. [Abstract] [Full-text]
29. Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay.
    Clin Chem, 55(1): 134-8. [Abstract] [Full-text]
30. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
    J Stroke Cerebrovasc Dis, 18(1): 74-7. [Abstract] [Full-text]
31. The stroke that struck back: an unusual alien hand presentation.
    J Stroke Cerebrovasc Dis, 18(1): 72-3. [Abstract] [Full-text]
32. Sequential combination of two intravenous thrombolytics (recombinant tissue plasminogen activator/tenecteplase) in a patient with stroke and cardioembolic basilar artery occlusion.
    J Stroke Cerebrovasc Dis, 18(1): 68-71. [Abstract] [Full-text]
33. Locomotion outcome in hemiplegic patients with middle cerebral artery infarction: the difference between right- and left-sided lesions.
    J Stroke Cerebrovasc Dis, 18(1): 60-7. [Abstract] [Full-text]
34. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
    J Stroke Cerebrovasc Dis, 18(1): 56-9. [Abstract] [Full-text]
35. Neuroprosthesis for footdrop compared with an ankle-foot orthosis: effects on postural control during walking.
    J Stroke Cerebrovasc Dis, 18(1): 41-7. [Abstract] [Full-text]
36. A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack.
    J Stroke Cerebrovasc Dis, 18(1): 38-40. [Abstract] [Full-text]
37. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    J Stroke Cerebrovasc Dis, 18(1): 32-7. [Abstract] [Full-text]
38. A case of unilateral thalamic hemorrhagic infarction as a result of the vein of Galen and straight sinus thrombosis.
    J Stroke Cerebrovasc Dis, 18(1): 28-31. [Abstract] [Full-text]
39. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.
    J Stroke Cerebrovasc Dis, 18(1): 23-7. [Abstract] [Full-text]
40. Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement.
    J Stroke Cerebrovasc Dis, 18(1): 17-22. [Abstract] [Full-text]
41. Stroke in Spain: epidemiologic incidence and patterns; a health sentinel network study.
    J Stroke Cerebrovasc Dis, 18(1): 11-6. [Abstract] [Full-text]
42. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid artery stent placement with distal balloon protection.
    J Vasc Interv Radiol, 20(1): 9-16. [Abstract] [Full-text]
43. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition.
    Biochem Biophys Res Commun, 378(3): 507-12. [Abstract] [Full-text]
44. Multimodal magnetic resonance imaging for assessing evolution of ischemic penumbra: a key translational medicine strategy to manage the risk of developing novel therapies for acute ischemic stroke.
    J Cereb Blood Flow Metab, 29(1): 217-9. [Abstract] [Full-text]
45. Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis.
    J Cereb Blood Flow Metab, 29(1): 157-65. [Abstract] [Full-text]
46. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.
    J Cereb Blood Flow Metab, 29(1): 119-29. [Abstract] [Full-text]
47. Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction.
    J Cereb Blood Flow Metab, 29(1): 34-8. [Abstract] [Full-text]

© 2004-2010 Stroke Research Today. All Rights Reserved.